Search research articles
Contact Us
Filters
Showing results (801-810 of 823) with videos related to
Page
of 83
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Mutations, Recombination and Insertion in the Evolution of 2019-nCoV
Aiping Wu, Peihua Niu, Lulan Wang, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
Yachang Huo, Dan Wang, Shuangning Yang, et al.
Journal of Hepatology
|
May 17, 2017
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding
Qiuhe Wang, Yong Lv, Ming Bai, et al.
Investigational New Drugs
|
July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC
Enxin Wang, Dongdong Xia, Wei Bai, et al.
Cell Metabolism
|
May 3, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Xinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
BMC Gastroenterology
|
May 12, 2026
Urban-rural disparities in survival of Chinese esophageal squamous cell carcinoma: a cohort study of 133,064 cases
Ran Wang, Zong Min Fan, Kan Zhong, et al.
World Journal of Gastroenterology
|
January 2, 2026
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China
Meng-Xia Wei, Ling-Ling Lei, Rui-Hua Xu, et al.
Gut
|
October 4, 2017
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial
Yong Lv, Xingshun Qi, Chuangye He, et al.
Cell Metabolism
|
February 8, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Xinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
JAMA Oncology
|
June 26, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial
Hui Li, Kaiyan Chen, Lei Gong, et al.
Page
of 83
Search research articles
Search
Showing results (801-810 of 823) with videos related to
Sort By:
Page
of 83
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Mutations, Recombination and Insertion in the Evolution of 2019-nCoV
Aiping Wu, Peihua Niu, Lulan Wang, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
Yachang Huo, Dan Wang, Shuangning Yang, et al.
Journal of Hepatology
|
May 17, 2017
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding
Qiuhe Wang, Yong Lv, Ming Bai, et al.
Investigational New Drugs
|
July 19, 2018
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC
Enxin Wang, Dongdong Xia, Wei Bai, et al.
Cell Metabolism
|
May 3, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Xinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
BMC Gastroenterology
|
May 12, 2026
Urban-rural disparities in survival of Chinese esophageal squamous cell carcinoma: a cohort study of 133,064 cases
Ran Wang, Zong Min Fan, Kan Zhong, et al.
World Journal of Gastroenterology
|
January 2, 2026
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China
Meng-Xia Wei, Ling-Ling Lei, Rui-Hua Xu, et al.
Gut
|
October 4, 2017
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial
Yong Lv, Xingshun Qi, Chuangye He, et al.
Cell Metabolism
|
February 8, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Xinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
JAMA Oncology
|
June 26, 2025
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial
Hui Li, Kaiyan Chen, Lei Gong, et al.
Page
of 83